INO:NASDAQ
Inovio Pharmaceuticals Inc
၁.၇၂ US$
arrow_upward
+၁.၄၈%(+၀.၀၂၅) 1D
နို ၁၉, GMT-၅ ၁၄:၂၇:၀၁ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
၁.၇၂ US$
High
၁.၇၆ US$
Low
၁.၆၃ US$
Mkt. cap
၃၂.၁၂ ကုဋေ
Avg. vol.
၂.၀၂ ကုဋေ
Volume
၆.၄၇ သန်း
52-wk high
၂.၇၂ US$
52-wk low
၀.၅၇ US$
EPS
-၀.၈၀ US$
Beta
၁.၇၁
Shares outstanding
၁၈.၇၃ ကုဋေ
No. of employees
၁၁၂
Open
၁.၇၂ US$
High
၁.၇၆ US$
Low
၁.၆၃ US$
Mkt. cap
၃၂.၁၂ ကုဋေ
Avg. vol.
၂.၀၂ ကုဋေ
Volume
၆.၄၇ သန်း
52-wk high
၂.၇၂ US$
52-wk low
၀.၅၇ US$
EPS
-၀.၈၀ US$
Beta
၁.၇၁
Shares outstanding
၁၈.၇၃ ကုဋေ
No. of employees
၁၁၂
News stories
From web sources and news partners
Investing.com
·
ပြီးခဲ့သည့် ၂၀ နာရီ
Inovio at Jefferies Global Healthcare Conference: launch begins
News Corp
·
ပြီးခဲ့သည့် ၂၁ နာရီ
Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day
Investing.com
·
ပြီးခဲ့သည့် ၁ ရက်
Inovio submits European approval application for RRP treatment
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc